These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34607731)

  • 1. Effectiveness of a substance use treatment program for veterans with chronic pain and opioid use disorder.
    Ward R; Tang YL; Axon RN; Casarella J; Whitfield N; Rauch SAM
    J Subst Abuse Treat; 2022 Jan; 132():108635. PubMed ID: 34607731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a non-pharmacological interdisciplinary pain rehabilitation and functional restoration program for chronic pain in veterans.
    Ward R; Rauch SAM; Axon RN; Saenger MS
    Health Serv Res; 2023 Apr; 58(2):365-374. PubMed ID: 36064854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
    Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
    Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
    Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
    Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
    Rogal S; Youk A; Agbalajobi O; Zhang H; Gellad W; Fine MJ; Belperio P; Morgan T; Good CB; Kraemer K
    Am J Gastroenterol; 2021 Jul; 116(7):1406-1413. PubMed ID: 33811202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of a multisite randomized clinical trial examining an integrated behavioral treatment for veterans with co-occurring chronic pain and opioid use disorder: The pain and opioids integrated treatment in veterans (POSITIVE) trial.
    Vowles KE; Witkiewitz K; Clarke E; Schmidt Z; Borsari B; Edwards KE; Korecki JR; Moniz-Lewis DI; Bondzie JA; Mullins C; Thoreson CI; Delacruz J; Wilkins CH; Nelson S; Delventura J; Henderson R; Katz A; Hua W; Watson E; Baxley C; Canlas BR; Pendleton T; Herbst E; Batki S
    Contemp Clin Trials; 2023 Mar; 126():107096. PubMed ID: 36693589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder.
    DeRonne BM; Wong KR; Schultz E; Jones E; Krebs EE
    Am J Health Syst Pharm; 2021 Feb; 78(4):354-359. PubMed ID: 33326564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention.
    Smith A; Hansen J; Colvard M
    J Subst Abuse Treat; 2021 Nov; 130():108440. PubMed ID: 34118708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System.
    Hawkins EJ; Malte CA; Gordon AJ; Williams EC; Hagedorn HJ; Drexler K; Blanchard BE; Burden JL; Knoeppel J; Danner AN; Lott A; Liberto JG; Saxon AJ
    JAMA Netw Open; 2021 Dec; 4(12):e2137238. PubMed ID: 34870679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid use disorder with chronic pain increases disease burden and service use.
    MacLean RR; Sofuoglu M; Stefanovics E; Rosenheck R
    Psychol Serv; 2023 Feb; 20(1):157-165. PubMed ID: 34968125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing Pharmacological Treatments for Opioid Use Disorder (ADaPT-OUD): an Implementation Trial in Eight Veterans Health Administration Facilities.
    Hagedorn HJ; Gustavson AM; Ackland PE; Bangerter A; Bounthavong M; Clothier B; Harris AHS; Kenny ME; Noorbaloochi S; Salameh HA; Gordon AJ
    J Gen Intern Med; 2022 Nov; 37(14):3594-3602. PubMed ID: 34981352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-occurring implementation strategies: The effects of academic detailing for opioid use disorder campaign on the advancing pharmacological treatments for opioid use disorder (ADaPT-OUD) study.
    Miller WA; Gordon AJ; Clothier BA; Ackland PE; Bounthavong M; Garcia C; Kenny ME; Noorbaloochi S; Hagedorn HJ
    Implement Res Pract; 2023; 4():26334895231199463. PubMed ID: 37790176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study.
    Morse E; Binswanger IA; Taylor E; Gray C; Stimmel M; Timko C; Harris AHS; Smelson D; Finlay AK
    J Subst Abuse Treat; 2021 Oct; 129():108353. PubMed ID: 34080564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating cognitive bias modification for pain and opioid cues into medication for opioid use disorder clinical care: Feasibility, acceptability, and preliminary results.
    MacLean RR; Heapy AA; Waters AJ; Wolkowicz N; Szollosy SK; Meyerovich J; Sofuoglu M
    Drug Alcohol Depend; 2023 May; 246():109857. PubMed ID: 37004461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders.
    Frost MC; Malte CA; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
    J Subst Use Addict Treat; 2023 Dec; 155():209175. PubMed ID: 37751798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cascade of care for opioid use disorder among youth in British Columbia, 2018.
    Krebs E; Min JE; Zhou H; Davison C; McGowan G; Nosyk B
    J Subst Abuse Treat; 2021 Nov; 130():108404. PubMed ID: 34118696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration.
    Gordon AJ; Saxon AJ; Kertesz S; Wyse JJ; Manhapra A; Lin LA; Chen W; Hansen J; Pinnell D; Huynh T; Baylis JD; Cunningham FE; Ghitza UE; Bart G; Yu H; Sauer BC
    Drug Alcohol Depend; 2023 Jul; 248():109902. PubMed ID: 37196572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder.
    Seal KH; Maguen S; Bertenthal D; Batki SL; Striebel J; Stein MB; Madden E; Neylan TC
    J Clin Psychiatry; 2016 Sep; 77(9):1182-1188. PubMed ID: 27035058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.